Gina Chapman
Cargo Therapeutics, Inc.
Gina Chapman is the CEO of Cargo Therapeutics, Inc., a biopharmaceutical company specializing in developing novel therapies for cancer and other serious diseases. Chapmans leadership is characterized by a focus on scientific innovation, clinical development, and strategic growth. With extensive experience in biotechnology and drug development, she has been pivotal in advancing Cargo Therapeutics research and clinical programs. Her commitment to leveraging cutting-edge technologies and addressing unmet medical needs drives the companys mission to develop transformative therapies. Under her leadership, Cargo Therapeutics continues to make significant strides in biopharmaceutical innovation and patient care.